Tg Therapeutics (TGTX) Debt Ratio (2010 - 2026)

Tg Therapeutics' Debt Ratio history runs 13 years deep, the most recent figure standing at 0.49 for Q1 2026.

• In Q1 2026, Debt Ratio rose 30.78% year-over-year to 0.49; the TTM figure through Mar 2026 stood at 0.49 (up 30.78% YoY), while the FY2025 annual figure was 0.23, down 45.4% from the prior year.
• Debt Ratio was 0.49 for Q1 2026 at Tg Therapeutics, up from 0.23 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.49 in Q1 2023 to a low of 0.22 in Q1 2022.
• Historically, Debt Ratio has averaged 0.34 across 5 years, with a median of 0.33 in 2022.
• The sharpest annual moves came in 2022 and 2025: Debt Ratio soared 735.99% in 2022, then slumped 45.4% in 2025.
• A 5-year view of Debt Ratio shows it stood at 0.37 in 2022, then declined by 17.34% to 0.3 in 2023, then soared by 39.29% to 0.42 in 2024, then plunged by 45.4% to 0.23 in 2025, then soared by 110.96% to 0.49 in 2026.
• The last three Debt Ratio figures came in at 0.49 (Q1 2026), 0.23 (Q4 2025), and 0.24 (Q3 2025), per Business Quant data.